Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Consolidated Net Income (2016 - 2024)

Arcadia Biosciences' Consolidated Net Income history spans 11 years, with the latest figure at -$27000.0 for Q4 2024.

  • For Q4 2024, Consolidated Net Income rose 98.76% year-over-year to -$27000.0; the TTM value through Sep 2025 reached -$27000.0, up 99.45%, while the annual FY2024 figure was -$2.7 million, 65.28% up from the prior year.
  • Consolidated Net Income reached -$27000.0 in Q4 2024 per RKDA's latest filing, up from -$430000.0 in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $14.1 million in Q4 2020 to a low of -$9.9 million in Q2 2020.
  • Average Consolidated Net Income over 5 years is -$1.9 million, with a median of -$1.6 million recorded in 2021.
  • Peak YoY movement for Consolidated Net Income: soared 204.8% in 2020, then crashed 715.47% in 2024.
  • A 5-year view of Consolidated Net Income shows it stood at $14.1 million in 2020, then plummeted by 167.69% to -$9.6 million in 2021, then skyrocketed by 87.98% to -$1.1 million in 2022, then tumbled by 89.11% to -$2.2 million in 2023, then skyrocketed by 98.76% to -$27000.0 in 2024.
  • Per Business Quant, the three most recent readings for RKDA's Consolidated Net Income are -$27000.0 (Q4 2024), -$430000.0 (Q3 2024), and -$789000.0 (Q2 2024).